Author

B. A. H. Smith

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. Li· 1 shared C. K. Tsui· 1 shared C. R. Bertozzi· 1 shared C. R. Fischer· 1 shared D. Rabuka· 1 shared D. W. Morgens· 1 shared M. C. Bassik· 1 shared R. M. Barfield· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Li

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systematic identification of regulators of antibody-drug conjugate toxicity using CRISPR-Cas9 screens

C. K. Tsui, R. M. Barfield, C. R. Fischer, D. W. Morgens, A. Li, B. A. H. Smith, C. R. Bertozzi, D. Rabuka, M. C. Bassik

This study uses CRISPR-Cas9 screens to identify genes regulating antibody-drug conjugate (ADC) toxicity, revealing endolysosomal trafficking regulators and mechanisms of ADC resistance.

bioRxiv · Mar 3, 2019 · PreprintCancer Biology